Mail

Mail Promises, Promises Ok, this article about the dangers of scientific predictions1 is well written—but it is not saying anything hundreds have not said. Scientists make crazy promises. Hubris causes us to assert that we know what is right as though we have not been bitten by unintended consequences many, many times. But…there is plenty of blame to go around. Patients demand cures for complex diseases as though merely stomping your

Written byThe Scientist
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Ok, this article about the dangers of scientific predictions1 is well written—but it is not saying anything hundreds have not said. Scientists make crazy promises. Hubris causes us to assert that we know what is right as though we have not been bitten by unintended consequences many, many times. But…there is plenty of blame to go around. Patients demand cures for complex diseases as though merely stomping your feet and demanding cures is enough. Scientists respond by looking for cures with artificial models that barely approach real diseases. Scientists have been abandoned by their institutions and turned into money-scroungers with no choice but to turn to the tricks of marketing.

What if we stop writing and saying these things and take it all seriously? Is anyone really ready to give up the game?

Susan Fitzpatrick
James S. McDonnell Foundation
St. Louis, Mo.
susan@jsmf.org

Dire predictions by Paul Ehrlich about overpopulation and mass ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies